Table 1.
The dose constrains and the relative priority used during optimization for multiple partial VMAT planning.
| Structures | Criteria | Dose Limit (% of Rx dose)/(Gy) | Priority (Level 1–3) | Priority (Level 4–5) | ||
|---|---|---|---|---|---|---|
| PTV |
|
of Rx | 120 | 400 | ||
| Maximum dose | 0% |
|
250 | 450 | ||
| Heart | Mean dose | 9Gy | 120 | 120 | ||
|
|
<70% | |||||
|
|
<30% | |||||
|
|
<5% | |||||
|
|
|
|||||
| Left Lung | Mean dose | 10Gy | 80–250 | 80–250 | ||
|
|
<45% | |||||
|
|
<30% | |||||
|
|
<15% | |||||
| Right Lung | Mean dose | 4Gy | ||||
|
|
<20% | 120–250 | 120–250 | |||
|
|
|
|||||
| TLV | Mean dose | 6.5Gy | ||||
|
|
<25% | none | none | |||
|
|
<10% | |||||
| Right Breast | Mean dose | 2.5Gy | 120–250 | 120–250 | ||
| Maximum dose | 10Gy | |||||
|
|
<5% | |||||
|
|
|
Rx: prescription; TLV: total lung volume